NIH researchers discover highly infectious vehicle for transmission of viruses among humans

NIH researchers discover highly infectious vehicle for transmission of viruses among humans

Researchers have found that a group of viruses that cause severe stomach illness — including the one famous for widespread outbreaks on cruise ships — get transmitted to humans through membrane-cloaked “virus clusters” that exacerbate the spread and severity of disease. Previously, it was believed that these viruses only spread through individual virus particles. The discovery of these clusters, the scientists say, marks a turning point in the understanding of how these viruses spread and why they are so infectious. This preliminary work could lead to the development of more effective antiviral agents than existing treatments that mainly target individual particles.

The researchers studied norovirus (link is external) and rotavirus (link is external)–hard-to-treat viruses that are the most common cause of stomach illness, or gastroenteritis, and that afflicts millions of people each year. The viruses cause symptoms ranging from diarrhea to abdominal pain and can sometimes result in death, particularly among young children and the elderly. Their highly contagious nature has led to serious outbreaks in crowded spaces throughout many communities; most notably in cruise ships, daycare centers, classrooms, and nursing homes. Fortunately, vaccines against rotavirus are now available and are routinely given to babies in the United States.

“This is a really exciting finding in the field of virology because it reveals a mode of virus spread that has not been observed among humans and animals,” said study leader Nihal Altan-Bonnet, Ph.D., senior investigator and head of the Laboratory of Host-Pathogen Dynamics at the National Heart, Lung, and Blood Institute (NHLBI). “We hope that it will provide new clues to fighting a wide range of diseases involving many types of viruses, including those that cause gastrointestinal illnesses, heart inflammation, certain respiratory illnesses, and even the common cold.”

The study was supported in part by the Intramural Research programs of the NHLBI and the National Institute of Allergy and Infectious Diseases (NIAID), both part of the National Institutes of Health. It is featured as the cover story of Cell Host & Microbe and appears online on August 8.

Until a few years ago, most scientists believed that viruses, particularly those responsible for stomach illnesses, could only behave as independent infectious agents. However, in 2015 Altan-Bonnet and her colleagues showed that polioviruses could transmit themselves in packets, or membrane-bound vesicles containing multiple virus particles. The scientists compared this new model of viral transmission to a Trojan horse: A group of membrane-bound viruses arrives at a host cell and deposits viruses in the cell while dodging detection by the immune system. The scientists did not know whether this system applied to animals and humans, or how effective these packets were in infecting host cells.

To find out, they focused on rotaviruses and noroviruses, which mainly get spread by accidentally ingesting tiny particles of an infected person’s stool — through, for example, contaminated food or liquids. The researchers obtained fecal samples of humans and animals (pigs and mice) and found that the viruses are shed in the stool as virus clusters inside membrane-bound packets. In addition, they found that these virus-containing vesicles were significantly more infectious than the free, unbound viruses within the samples.

Membrane-bound vesicles containing clusters of viruses,including rotavirus and norovirus,within the gut. 

Rotaviruses are shown in the large vesicles,while noroviruses are shown in the smaller vesicles. 

NIH Medical Arts

The researchers determined that the high level of infectiousness was likely due to the vesicles delivering many viruses at once to the target tissues; protecting their viral cargo from being destroyed by prolonged exposure to enzymes; and possibly by making their viral cargo invisible to the antibodies that are in the stool or gut of the host. More studies are needed, but the extreme potency of the virus packets, they said, has a clear consequence: it not only enhances the virus’ ability to spread more aggressively; it also increases the severity of the disease it causes. Handwashing (link is external) with soap and water helps prevent the spread of viruses.

“Our findings indicate that vesicle-cloaked viruses are highly virulent units of fecal-oral transmission, and highlight a need for antivirals targeting vesicles and virus clustering,” Altan-Bonnet noted.

NIH support also includes the following grant from NIAID: RO1-AI091985.

This press release describes a basic research finding. Basic research increases our understanding of human behavior and biology, which is foundational to advancing new and better ways to prevent, diagnose, and treat disease. Science is an unpredictable and incremental process — each research advance builds on past discoveries, often in unexpected ways. Most clinical advances would not be possible without the knowledge of fundamental basic research.

Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at https://www.nhlbi.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.